Literature DB >> 21507939

Liver X receptor beta (LXRbeta) interacts directly with ATP-binding cassette A1 (ABCA1) to promote high density lipoprotein formation during acute cholesterol accumulation.

Masako Hozoji-Inada1, Youichi Munehira, Kohjiro Nagao, Noriyuki Kioka, Kazumitsu Ueda.   

Abstract

Cells have evolved multiple mechanisms for maintaining cholesterol homeostasis, and, among these, ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux is highly regulated at the transcriptional level through the activity of the nuclear receptor liver X receptor (LXR). Here, we show that in addition to its well defined role in transcription, LXRβ directly binds to the C-terminal region ((2247)LTSFL(2251)) of ABCA1 to mediate its post-translational regulation. In the absence of cholesterol accumulation in the macrophage-like cell line THP-1, the ABCA1-LXRβ complex stably localizes to the plasma membrane, but apolipoprotein A-I (apoA-I) binding or cholesterol efflux does not occur. Exogenously added LXR ligands, which mimic cholesterol accumulation, cause LXRβ to dissociate from ABCA1, thus freeing ABCA1 for apoA-I binding and subsequent cholesterol efflux. Photoaffinity labeling experiments with 8-azido-[α-(32)P]ATP showed that the interaction of LXRβ with ABCA1 inhibits ATP binding by ABCA1. This is the first study to show that a protein-protein interaction with the endogenous protein suppresses the function of ABC proteins by inhibiting ATP binding. LXRβ can cause a post-translational response by binding directly to ABCA1, as well as a transcriptional response, to maintain cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507939      PMCID: PMC3103384          DOI: 10.1074/jbc.M111.235846

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

Review 3.  Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene.

Authors:  Roshni R Singaraja; Liam R Brunham; Henk Visscher; John J P Kastelein; Michael R Hayden
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-22       Impact factor: 8.311

4.  Non-equivalent cooperation between the two nucleotide-binding folds of P-glycoprotein.

Authors:  Y Takada; K Yamada; Y Taguchi; K Kino; M Matsuo; S J Tucker; T Komano; T Amachi; K Ueda
Journal:  Biochim Biophys Acta       Date:  1998-08-14

5.  A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains.

Authors:  Raphaël Métivier; Alexander Stark; Gilles Flouriot; Michael R Hübner; Heike Brand; Graziella Penot; Dominique Manu; Stefanie Denger; George Reid; Martin Kos; Robert B Russell; Olivier Kah; Farzad Pakdel; Frank Gannon
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

6.  Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP).

Authors:  Y Taguchi; A Yoshida; Y Takada; T Komano; K Ueda
Journal:  FEBS Lett       Date:  1997-01-13       Impact factor: 4.124

7.  P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.

Authors:  I L Urbatsch; B Sankaran; J Weber; A E Senior
Journal:  J Biol Chem       Date:  1995-08-18       Impact factor: 5.157

8.  Alpha1-syntrophin modulates turnover of ABCA1.

Authors:  Youichi Munehira; Tomohiro Ohnishi; Shinobu Kawamoto; Akiko Furuya; Kenya Shitara; Michihiro Imamura; Toshifumi Yokota; Shin'ichi Takeda; Teruo Amachi; Michinori Matsuo; Noriyuki Kioka; Kazumitsu Ueda
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

9.  A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.

Authors:  Nan Wang; Wengen Chen; Patrick Linsel-Nitschke; Laurent O Martinez; Birgit Agerholm-Larsen; David L Silver; Alan R Tall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.

Authors:  Emi Kaneko; Morihiro Matsuda; Yukio Yamada; Yoji Tachibana; Iichiro Shimomura; Makoto Makishima
Journal:  J Biol Chem       Date:  2003-07-07       Impact factor: 5.157

View more
  13 in total

Review 1.  Role of the steroidogenic acute regulatory protein in health and disease.

Authors:  Pulak R Manna; Cloyce L Stetson; Andrzej T Slominski; Kevin Pruitt
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 2.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

3.  ABCA1/ApoE/HDL Pathway Mediates GW3965-Induced Neurorestoration After Stroke.

Authors:  Xu Cui; Michael Chopp; Zhenggang Zhang; Rongwen Li; Alex Zacharek; Julie Landschoot-Ward; Poornima Venkat; Jieli Chen
Journal:  Stroke       Date:  2016-12-27       Impact factor: 7.914

4.  Small GTPase ARF6 Regulates Endocytic Pathway Leading to Degradation of ATP-Binding Cassette Transporter A1.

Authors:  Nigora Mukhamedova; Anh Hoang; Huanhuan L Cui; Irena Carmichael; Ying Fu; Michael Bukrinsky; Dmitri Sviridov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

Review 5.  Role of liver X receptors in cholesterol efflux and inflammatory signaling (review).

Authors:  Rongtao Zhu; Zhibing Ou; Xiongzhong Ruan; Jianping Gong
Journal:  Mol Med Rep       Date:  2012-01-17       Impact factor: 2.952

6.  Phenotypic severity in a family with MEND syndrome is directly associated with the accumulation of potentially functional variants of cholesterol homeostasis genes.

Authors:  María Carmen Barboza-Cerda; Oralia Barboza-Quintana; Gerardo Martínez-Aldape; Raquel Garza-Guajardo; Miguel Angel Déctor
Journal:  Mol Genet Genomic Med       Date:  2019-08-08       Impact factor: 2.183

7.  Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells.

Authors:  V Derangère; A Chevriaux; F Courtaut; M Bruchard; H Berger; F Chalmin; S Z Causse; E Limagne; F Végran; S Ladoire; B Simon; W Boireau; A Hichami; L Apetoh; G Mignot; F Ghiringhelli; C Rébé
Journal:  Cell Death Differ       Date:  2014-08-15       Impact factor: 15.828

8.  Many ABCs make light work with cholesterol.

Authors:  Dmitri Sviridov
Journal:  Aging (Albany NY)       Date:  2013-09       Impact factor: 5.682

9.  Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis.

Authors:  Neelam Srivastava; Angelo B Cefalu; Maurizio Averna; Rai A K Srivastava
Journal:  Front Physiol       Date:  2018-09-11       Impact factor: 4.566

10.  Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR.

Authors:  Weiqing Shao; Wenwei Zhu; Jing Lin; Mengjun Luo; Zhifei Lin; Lu Lu; Huliang Jia; Lunxiu Qin; Ming Lu; Jinhong Chen
Journal:  Neoplasia       Date:  2019-11-18       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.